AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
MINIMAL RESIDUAL DISEASE IN AUTOLOGOUS HEMATOPOIETIC HARVESTS FROM BREAST-CANCER PATIENTS
Authors: SPYRIDONIDIS A BERNHARDT W FETSCHER S BEHRINGER D MERTELSMANN R HENSCHLER R
Citation: A. Spyridonidis et al., MINIMAL RESIDUAL DISEASE IN AUTOLOGOUS HEMATOPOIETIC HARVESTS FROM BREAST-CANCER PATIENTS, Annals of oncology, 9(8), 1998, pp. 821-826
THE CLINICAL ROLE OF GROWTH-FACTORS IN THE TREATMENT OF BREAST-CANCER
Authors: FETSCHER S MERTELSMANN K
Citation: S. Fetscher et K. Mertelsmann, THE CLINICAL ROLE OF GROWTH-FACTORS IN THE TREATMENT OF BREAST-CANCER, Biomedicine & pharmacotherapy, 52(3), 1998, pp. 101-108
MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER
Authors: BRUGGER W FETSCHER S HASSE J FROMMHOLD H PRESSLER K MERTELSMANN R ENGELHARDT R KANZ L
Citation: W. Brugger et al., MULTIMODALITY TREATMENT INCLUDING EARLY HIGH-DOSE CHEMOTHERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LIMITED-DISEASE SMALL-CELL LUNG-CANCER, Seminars in oncology, 25(1), 1998, pp. 42-48
PREOPERATIVE RADIOCHEMOTHERAPY OF ESOPHAGEAL CANCER - A PROGRESS
Authors: IMDAHL A JENKNER J HENKE M FETSCHER S RUF G FARTHMANN EH
Citation: A. Imdahl et al., PREOPERATIVE RADIOCHEMOTHERAPY OF ESOPHAGEAL CANCER - A PROGRESS, Gastroenterology, 114(4), 1998, pp. 2527-2527
HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES
Authors: FETSCHER S FINKE J ENGELHARDT R MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION IN PATIENTS WITH 2ND PRIMARY MALIGNANCIES, HEM CELL TH, 39(2), 1997, pp. 79-83
EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: FETSCHER S FINKE J ENGELHARDT R MERTELSMANN R LANGE W
Citation: S. Fetscher et al., EARLY-ONSET SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Annals of hematology, 74(2), 1997, pp. 73-77
CORRELATION BETWEEN PHYSICAL PERFORMANCE AND FATIGUE IN CANCER-PATIENTS
Authors: DIMEO F STIEGLITZ RD NOVELLIFISCHER U FETSCHER S MERTELSMANN R KEUL J
Citation: F. Dimeo et al., CORRELATION BETWEEN PHYSICAL PERFORMANCE AND FATIGUE IN CANCER-PATIENTS, Annals of oncology, 8(12), 1997, pp. 1251-1255
DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER
Authors: FETSCHER S BRUGGER W ENGELHARDT R KANZ L HASSE J FROMMHOLD H WENGER M LANGE W MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 100 CONSECUTIVE PATIENTS WITH, LIMITED-DISEASE AND EXTENSIVE-DISEASE SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 49-56
DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER
Authors: FETSCHER S BRUGGER W ENGELHARDT R KANZ L HASSE J FROMMHOLD H WENGER M LANGE W MERTELSMANN R
Citation: S. Fetscher et al., DOSE-INTENSE THERAPY WITH ETOPOSIDE, IFOSFAMIDE, CISPLATIN, AND EPIRUBICIN (VIP-E) IN 107 CONSECUTIVE PATIENTS WITH, LIMITED-STAGE AND EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER, Annals of oncology, 8(1), 1997, pp. 57-64
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR METASTATIC GASTRIC LEIOMYOSARCOMA
Authors: FETSCHER S BRUGGER W BERTZ H KRIEGER G KANZ L MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR METASTATIC GASTRIC LEIOMYOSARCOMA, Bone marrow transplantation, 20(9), 1997, pp. 787-788
TREATMENT OF RELAPSED NON-HODGKINS-LYMPHOMA AFTER BEAM CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION BY BU CY CHEMOTHERAPY AND SALVAGE TRANSPLANTATION/
Authors: FETSCHER S LUBBERT M KANZ L BEHRINGER D FINKE J MERTELSMANN R LANGE W
Citation: S. Fetscher et al., TREATMENT OF RELAPSED NON-HODGKINS-LYMPHOMA AFTER BEAM CHEMOTHERAPY AND AUTOLOGOUS TRANSPLANTATION BY BU CY CHEMOTHERAPY AND SALVAGE TRANSPLANTATION/, Bone marrow transplantation, 19(5), 1997, pp. 527-528
ACUTE MYELOMONOCYTIC LEUKEMIA SECONDARY TO SYNCHRONOUS CARCINOMAS OF THE BREAST AND LUNG, AND TO METACHRONOUS RENAL-CELL CARCINOMA
Authors: POTZSCH C FETSCHER S MERTELSMANN R LUBBERT M
Citation: C. Potzsch et al., ACUTE MYELOMONOCYTIC LEUKEMIA SECONDARY TO SYNCHRONOUS CARCINOMAS OF THE BREAST AND LUNG, AND TO METACHRONOUS RENAL-CELL CARCINOMA, Journal of cancer research and clinical oncology, 123(11-12), 1997, pp. 678-680
EFFECTS OF AEROBIC EXERCISE ON THE PHYSICAL PERFORMANCE AND INCIDENCEOF TREATMENT-RELATED COMPLICATIONS AFTER HIGH-DOSE CHEMOTHERAPY
Authors: DIMEO F FETSCHER S LANGE W MERTELSMANN R KEUL J
Citation: F. Dimeo et al., EFFECTS OF AEROBIC EXERCISE ON THE PHYSICAL PERFORMANCE AND INCIDENCEOF TREATMENT-RELATED COMPLICATIONS AFTER HIGH-DOSE CHEMOTHERAPY, Blood, 90(9), 1997, pp. 3390-3394
EARLY-ONSET OF SECONDARY CHRONIC MYELOGENOUS LEUKEMIA AFTER HIGH-DOSECHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR SMALL-CELL LUNG-CANCER
Authors: FETSCHER S LUBBERT M WALLER CF MERTELSMANN R LANGE W
Citation: S. Fetscher et al., EARLY-ONSET OF SECONDARY CHRONIC MYELOGENOUS LEUKEMIA AFTER HIGH-DOSECHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR SMALL-CELL LUNG-CANCER, Blood, 90(10), 1997, pp. 3989-3989
INCIDENCE AND MORBIDITY OF HERPES-ZOSTER INFECTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: FETSCHER S TECHNAU K MERTENS R FINKE J MERTELSMANN R LANGE W
Citation: S. Fetscher et al., INCIDENCE AND MORBIDITY OF HERPES-ZOSTER INFECTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 1681-1681
NEOADJUVANT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR INOPERABLE RELAPSE OF NUCHAL LIPOSARCOMA RESISTANT TO STANDARD-DOSE CHEMOTHERAPY
Authors: FETSCHER S KIANI A KANZ L BRUGGER W LANGE W MERTELSMANN R
Citation: S. Fetscher et al., NEOADJUVANT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR INOPERABLE RELAPSE OF NUCHAL LIPOSARCOMA RESISTANT TO STANDARD-DOSE CHEMOTHERAPY, Annals of oncology, 7(8), 1996, pp. 871-871
AN AEROBIC EXERCISE PROGRAM FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION
Authors: DIMEO F BERTZ H FINKE J FETSCHER S MERTELSMANN R KEUL J
Citation: F. Dimeo et al., AN AEROBIC EXERCISE PROGRAM FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1157-1160
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - EFFICACY AND TOXICITY OF A HIGH-DOSE RHG-CSF REGIMEN
Authors: WALLER CF BERTZ H WENGER MK FETSCHER S HARDUNG M ENGELHARDT M BEHRINGER D LANGE W MERTELSMANN R FINKE J
Citation: Cf. Waller et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION - EFFICACY AND TOXICITY OF A HIGH-DOSE RHG-CSF REGIMEN, Bone marrow transplantation, 18(2), 1996, pp. 279-283
COMPUTED-TOMOGRAPHY (CT) AND MAGNETIC-RESONANCE (MR) IMAGING OF THE HEAD PRIOR TO HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION
Authors: FETSCHER S MERTENS R TECHNAU K LAUBENBERGER J SCHNEIDER B FINKE J LANGE W LANGER J MERTELSMANN R
Citation: S. Fetscher et al., COMPUTED-TOMOGRAPHY (CT) AND MAGNETIC-RESONANCE (MR) IMAGING OF THE HEAD PRIOR TO HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 3743-3743
HIGH-DOSE REAM CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION BY HIGH-DOSE BU CY AND SALVAGE STEM-CELL TRANSPLANTATION/
Authors: FETSCHER S WALLER CF FINKE J DOLKEN G MERTELSMANN R LANGE W
Citation: S. Fetscher et al., HIGH-DOSE REAM CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION BY HIGH-DOSE BU CY AND SALVAGE STEM-CELL TRANSPLANTATION/, Blood, 88(10), 1996, pp. 3798-3798
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH BREAST-CANCER - A PROSPECTIVE RANDOMIZED TRIAL COMPARING RHG-CSF VS. RHG-CSF PLUS RHERYTHROPOIETIN (EPO) AFTER VIC-E CHEMOTHERAPY
Authors: VONLINTIG F WALLER CF MUSAHL V FETSCHER S ENGELKE R PETERS HD MERTELSMANN R LANGE W
Citation: F. Vonlintig et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH BREAST-CANCER - A PROSPECTIVE RANDOMIZED TRIAL COMPARING RHG-CSF VS. RHG-CSF PLUS RHERYTHROPOIETIN (EPO) AFTER VIC-E CHEMOTHERAPY, Blood, 88(10), 1996, pp. 1620-1620
PHILADELPHIA-CHROMOSOME NEGATIVE HEMATOPOIETIC PROGENITORS CAN BE MOBILIZED IN CML PATIENTS IN EARLY CHRONIC PHASE BY ICE CHEMOTHERAPY FOLLOWED BY SIMULTANEOUS ADMINISTRATION OF IL-3 AND G-CSF
Authors: WALLER CF HEINZINGER M FETSCHER S BURGER KJ MERTELSMANN R LANGE W
Citation: Cf. Waller et al., PHILADELPHIA-CHROMOSOME NEGATIVE HEMATOPOIETIC PROGENITORS CAN BE MOBILIZED IN CML PATIENTS IN EARLY CHRONIC PHASE BY ICE CHEMOTHERAPY FOLLOWED BY SIMULTANEOUS ADMINISTRATION OF IL-3 AND G-CSF, Blood, 88(10), 1996, pp. 1623-1623
INCIDENCE AND MORTALITY OF PULMONARY ASPERGILLOSIS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: FETSCHER S POTTHOFF K TECHNAU K MERTENS R WALLER CF FINKE J MERTELSMANN R LANGE W
Citation: S. Fetscher et al., INCIDENCE AND MORTALITY OF PULMONARY ASPERGILLOSIS AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 1658-1658
78-YEAR-OLD PATIENT WITH CHRONIC UPPER AB DOMINAL-PAIN HIGH-GRADE MALIGNANT B-CELL NON-HODGKINS-LYMPHOMA
Authors: FETSCHER S BAYERDORFFER E FINKE J
Citation: S. Fetscher et al., 78-YEAR-OLD PATIENT WITH CHRONIC UPPER AB DOMINAL-PAIN HIGH-GRADE MALIGNANT B-CELL NON-HODGKINS-LYMPHOMA, Der Internist, 36(12), 1995, pp. 1182-1189
SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: FETSCHER S LANGE W FINKE J BERTZ E MERTELSMANN R
Citation: S. Fetscher et al., SECONDARY MALIGNANCIES AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Blood, 86(10), 1995, pp. 3768-3768
Risultati: 1-25 | 26-26